Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-PALLD antibody (450-530 aa) (STJ94950) | Login | Anti-PALLD antibody (450-530 aa) (STJ94950) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRKN antibody (1-50 aa) (STJ94956) | Login | Anti-PRKN antibody (1-50 aa) (STJ94956) | ||||||||||||||||
|
||||||||||||||||||
Anti-PARP2 antibody (151-200 aa) (STJ94959) | Login | Anti-PARP2 antibody (151-200 aa) (STJ94959) | ||||||||||||||||
|
||||||||||||||||||
Anti-PARP3 antibody (10-59 aa) (STJ94960) | Login | Anti-PARP3 antibody (10-59 aa) (STJ94960) | ||||||||||||||||
|
||||||||||||||||||
Anti-PARP4 antibody (1151-1200 aa) (STJ94961) | Login | Anti-PARP4 antibody (1151-1200 aa) (STJ94961) | ||||||||||||||||
|
||||||||||||||||||
Anti-PAX2 antibody (144-193 aa) (STJ94965) | Login | Anti-PAX2 antibody (144-193 aa) (STJ94965) | ||||||||||||||||
|
||||||||||||||||||
Anti-PAX8 antibody (145-194 aa) (STJ94967) | Login | Anti-PAX8 antibody (145-194 aa) (STJ94967) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDH3 antibody (51-100 aa) (STJ94979) | Login | Anti-CDH3 antibody (51-100 aa) (STJ94979) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDGFA antibody (105-154 aa) (STJ94995) | Login | Anti-PDGFA antibody (105-154 aa) (STJ94995) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDGFRA antibody (731-780 aa) (STJ95000) | Login | Anti-PDGFRA antibody (731-780 aa) (STJ95000) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDGFRB antibody (991-1040 aa) (STJ95003) | Login | Anti-PDGFRB antibody (991-1040 aa) (STJ95003) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDGFRB antibody (718-767 aa) (STJ95004) | Login | Anti-PDGFRB antibody (718-767 aa) (STJ95004) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDK1 antibody (80-160 aa) (STJ95009) | Login | Anti-PDK1 antibody (80-160 aa) (STJ95009) | ||||||||||||||||
|
||||||||||||||||||
Anti-PDPK1 antibody (210-259 aa) (STJ95010) | Login | Anti-PDPK1 antibody (210-259 aa) (STJ95010) | ||||||||||||||||
|
||||||||||||||||||
Anti-ETV4 antibody (281-330 aa) (STJ95021) | Login | Anti-ETV4 antibody (281-330 aa) (STJ95021) | ||||||||||||||||
|
||||||||||||||||||
Anti-PPHLN1 antibody (71-120 aa) (STJ95030) | Login | Anti-PPHLN1 antibody (71-120 aa) (STJ95030) | ||||||||||||||||
|
||||||||||||||||||
Anti-ABCB1 antibody (534-583 aa) (STJ95057) | Login | Anti-ABCB1 antibody (534-583 aa) (STJ95057) | ||||||||||||||||
|
||||||||||||||||||
Anti-ANP32B antibody (1-50 aa) (STJ95060) | Login | Anti-ANP32B antibody (1-50 aa) (STJ95060) | ||||||||||||||||
|
||||||||||||||||||
Anti-PIK3R5 antibody (695-744 aa) (STJ95073) | Login | Anti-PIK3R5 antibody (695-744 aa) (STJ95073) | ||||||||||||||||
|
||||||||||||||||||
Anti-LMNA antibody (361-410 aa) (STJ93885) | Login | Anti-LMNA antibody (361-410 aa) (STJ93885) | ||||||||||||||||
|
||||||||||||||||||
Anti-LDLRAD2 antibody (130-179 aa) (STJ93915) | Login | Anti-LDLRAD2 antibody (130-179 aa) (STJ93915) | ||||||||||||||||
|
||||||||||||||||||
Anti-LIMK1 antibody (471-520 aa) (STJ93927) | Login | Anti-LIMK1 antibody (471-520 aa) (STJ93927) | ||||||||||||||||
|
||||||||||||||||||
Anti-LIMK-1/2 antibody (481-530 aa) (STJ93929) | Login | Anti-LIMK-1/2 antibody (481-530 aa) (STJ93929) | ||||||||||||||||
|
||||||||||||||||||
Anti-STK11 antibody (384-433 aa) (STJ93937) | Login | Anti-STK11 antibody (384-433 aa) (STJ93937) | ||||||||||||||||
|
||||||||||||||||||
Anti-TRARG1 antibody (1-50 aa) (STJ93945) | Login | Anti-TRARG1 antibody (1-50 aa) (STJ93945) | ||||||||||||||||
|